glp 1 agonist anti inflammatory The anti-inflammatory and immunological properties of GLP-1 Receptor Agonists GLP-1 Agonists in Cardiovascular Diseases:
Description
A., Abou-Kheir, W., Davicioni, E., Lee, D
M.BuseJ
Long-acting injectable GLP-1 receptor agonists for the treatment of adults with type 2 diabetes: perspectives from clinical practice
The LIVE trial assessed the influence of liraglutide in patients with chronic HF and reduced left ventricular ejection fraction (LVEF 45%)
Policymakers are increasingly recognizing these potential savings and are exploring the idea of expanding coverage for these drugs under programs like Medicare, which could reduce long-term healthcare spending (Goldman & Ward, 2024)
Early data suggest even greater weight loss and metabolic benefits
